EMA — authorised 31 December 2009
- Application: EMEA/H/C/000747
- Marketing authorisation holder: Schering-Plough Europe
- Local brand name: Garenoxacin mesylate
- Status: withdrawn
🇪🇺 GARENOXACIN MESYLATE in European Union
EMA authorised GARENOXACIN MESYLATE on 31 December 2009
Marketing authorisation
GARENOXACIN MESYLATE in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is GARENOXACIN MESYLATE approved in European Union?
Yes. EMA authorised it on 31 December 2009.
Who is the marketing authorisation holder for GARENOXACIN MESYLATE in European Union?
Schering-Plough Europe holds the EU marketing authorisation.